Mar 23, 2026 | Clinical guidelines, Drug advertising, MedBen Rx, Rx Costs
Heavy direct-to-consumer advertising of high-cost medications is fueling patient demand and placing added pressure on physicians to prescribe the drugs that patients recognize — even when lower-cost alternatives may be just as, or more, effective. The scale of this...
Feb 23, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rx Costs, Specialty Drugs
Specialty medications continue to dominate pharmacy spend, now accounting for 52% of all U.S. pharmaceutical sales, according to a recent report from the Healthcare Distribution Alliance. With costs often reaching tens — or even hundreds — of thousands of dollars per...
Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Dec 29, 2025 | MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Transparency
While the major PBMs still dominate the market, their grip is loosening. A recent Pulse of the Purchaser survey found that the percentage of employers contracted with one of the Big 3 dropped from 72% in 2024 to 61% by late 2025, as more organizations shifted toward...
Dec 15, 2025 | GLP-1s, MedBen Rx, Medicaid, Pharmacy, Private employers, Weight loss, Weight loss drugs
In recent months, a growing number of U.S. states have pulled back on covering GLP-1 medications for obesity under their Medicaid programs, even as the drugs remain broadly covered for diabetes. A recent KFF survey shows that while 16 state Medicaid programs still...
Dec 2, 2025 | Alternative Reimbursement Strategies, Cost management, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, Health care costs, High-cost claims, MedBen Analytics, MedBen Rx, MedBen WellLiving, Rx Costs, Self-funding, Survey
As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....
